Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2018-03-09

Clinical Trial Update: Botulinum Toxin for Stomach Cancer Treatment [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating botulinum toxin for stomach cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Botulinum toxin (botulinum toxin)

Snippet

Sponsor: St. Olavs Hospital | Conditions: Stomach Neoplasms | Phase 2 | Status: COMPLETED